Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1

By Giunchedi Paolo  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 5, 2013-05 ,pp. : 679-690

Informa Healthcare

Access to resources Recommend Favorite

Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone

By Wang Yan-Bin   Chen Min-Hua   Yan Kun   Yang Wei   Dai Ying   Yin Shan-Shan  

Quality of Life Research, Vol. 16, Iss. 3, 2007-04 ,pp. : 389-397

Springer Publishing Company

Access to resources Recommend Favorite

Statin use and risk of hepatocellular carcinoma

By Lai Shih-Wei  

European Journal of Epidemiology, Vol. 28, Iss. 6, 2013-06 ,pp. : 485-492

Springer Publishing Company

Access to resources Recommend Favorite

Proxy ratings of health related quality of life in patients with hepatocellular carcinoma

By Steel Jennifer   Geller David   Carr Brian  

Quality of Life Research, Vol. 14, Iss. 4, 2005-05 ,pp. : 1025-1033

Springer Publishing Company

Access to resources Recommend Favorite

Overview

By  

International Journal of Child and Adolescent Health, Vol. , Iss. , 2017-01 ,pp. : 47-47

Nova Science Publishers, Inc.

Access to resources Recommend Favorite